Product Information
KLOR-CON M20 TABLET is a brand (anda) product labeled by Upsher-Smith Laboratories LLC, priced at $0.1422 per EA under NDC 00245531910. Its NADAC has been published 334 times since Sep 18, 2019.
FDA first approved this application on Nov 20, 1998. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1500 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245531910
Classification
Brand (ANDA)
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074726FDA Approved
11/20/1998
TE Code
AB1
On Market Since
1/18/2011
Pharmacological Classes
Price Statistics
The NADAC for KLOR-CON M20 TABLET has been published 334 times since Sep 18, 2019, and over the history we have for it it has declined 65.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1422 per EA |
|---|---|
| All-time high | $0.4159 (Sep 16, 2020) |
| All-time low | $0.0654 (Dec 18, 2024) |
| 52-week high | $0.1482 |
| 52-week low | $0.0670 |
| Median price | $0.1414 |
| Average price | $0.1900 |
| Largest weekly change | -49.2% (Nov 20, 2024) |
| Weeks tracked | 334 |
| Tracking since | Sep 18, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
potassium chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KLOR-CON M20 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KLOR-CON M20 TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.1422 per EA (NDC 00245531910), effective Sep 30, 2026.
How has the price of KLOR-CON M20 TABLET changed over time?
Over the history we have for it, the NADAC for KLOR-CON M20 TABLET has declined 65.8%. It has been tracked across 334 weekly CMS publications since Sep 18, 2019.
What are the highest and lowest recorded NADAC prices for KLOR-CON M20 TABLET?
Since Sep 18, 2019, the NADAC for KLOR-CON M20 TABLET has ranged from a low of $0.0654 (Dec 18, 2024) to a high of $0.4159 (Sep 16, 2020), with a median of $0.1414 per EA.
Are there cheaper alternatives to KLOR-CON M20 TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 20 MEQ TABLET, is $0.1366 per EA — about 4% below KLOR-CON M20 TABLET.
Who manufactures KLOR-CON M20 TABLET?
KLOR-CON M20 TABLET (NDC 00245531910) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand (anda) product.